How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,692 results for

Gestational Diabetes Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health. (Abstract)

Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health. Gestational diabetes mellitus (GDM) is a common medical condition that complicates pregnancy and causes adverse maternal and fetal outcomes. At present, most treatment strategies focus on normalisation of maternal blood glucose values with use of diet, lifestyle modification, exercise, oral anti-hyperglycaemics and insulin. This has been shown to reduce (...) the incidence of adverse outcomes, such as birth trauma and macrosomia. However, this involves intensive monitoring and treatment of all women with GDM. We propose that using medical imaging to identify pregnancies displaying signs of being affected by GDM could help to target management, allowing low-risk women to be spared excessive intervention, and facilitating better resource allocation.We wanted to address the following question: in women with gestational diabetes, does the use of fetal imaging plus

2019 Cochrane

2. Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants. Full Text available with Trip Pro

of the included study. The quality of the evidence was assessed using the GRADE approach.The findings of this review are based on a single trial involving 425 women with gestational diabetes. The trial compared induction of labour with expectant management (waiting for the spontaneous onset of labour in the absence of any maternal or fetal issues that may necessitate birth) in pregnant women with gestational diabetes at term. We assessed the overall risk of bias as being low for most domains, apart from (...) Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants. Gestational diabetes is a type of diabetes that occurs during pregnancy. Women with gestational diabetes are more likely to experience adverse health outcomes such as pre-eclampsia or polyhydramnios (excess amniotic fluid). Their babies are also more likely to have health complications such as macrosomia (birthweight > 4000 g) and being large-for-gestational age

2018 Cochrane

3. Health app: GDm-Health for people with gestational diabetes

Health app: GDm-Health for people with gestational diabetes Health app: GDm-Health for people with Health app: GDm-Health for people with gestational diabetes gestational diabetes Medtech innovation briefing Published: 13 November 2017 nice.org.uk/guidance/mib131 pathways Summary Summary About this app GDm-Health is a health application designed for people with gestational diabetes to allow for remote monitoring of blood glucose levels and communication with healthcare professionals. The mobile (...) this information to prioritise users for review. Improved communication using the app could potentially reduce the workload for healthcare professionals and the number of outpatient appointments. This would depend on current local protocols for managing gestational diabetes. Blood glucose and other information are recorded electronically, which allows for efficient data auditing. Current care pathway The NICE guideline on diabetes in pregnancy recommends that people with gestational diabetes should have

2017 National Institute for Health and Clinical Excellence - Advice

4. Detection and initial management of gestational diabetes through primary health care services in Morocco: An effectiveness-implementation trial. Full Text available with Trip Pro

Detection and initial management of gestational diabetes through primary health care services in Morocco: An effectiveness-implementation trial. Gestational Diabetes Mellitus (GDM) testing and management in Morocco is associated with delays resulting in late commencement of treatment. To reduce delays and to increase access of women to GDM care, a country-adapted intervention targeting primary health care providers was designed to test the hypothesis that detection and initial management of GDM (...) a delivery complication whereas more newborn complications were observed in women from intervention facilities. No difference between the two groups existed regarding mode of delivery and mean gestational age at delivery. One of the main limitations of the study was the Hawthorn-effect at control sites that might have led to an underestimation of the effect size.A high GDM prevalence in Morocco calls for a context-adapted screening and management approach to enable early interventions. GDM detection

2018 PLoS ONE Controlled trial quality: uncertain

5. Gestational diabetes

like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for gestational diabetes The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials (...) of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com Top results for gestational diabetes 1. Oral anti- diabetic agents for women with established diabetes /impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes . BACKGROUND: While most guidance recommends the use of insulin in women whose pregnancies are affected by pre-existing diabetes , oral anti

2018 Trip Latest and Greatest

6. Gestational Diabetes

Alberico S, Erenbourg A, Hod M, et al; GINEXMAL Group. Immediate delivery or expectant management in gestational diabetes at term: the GINEXMAL randomised controlled trial. BJOG. 2017 Mar;124(4):669- 677. Boulvain M, Senat MV, Perrotin F, et al; Groupe de Recherche en Obstétrique et Gynécologie. Induction of labour versus expectant management for large-for-date fetuses: a randomized controlled trial. Lancet. 2015 Jun 27;385(9987):2600-2605. Garrison A. Screening, diagnosis, and management (...) Gestational Diabetes © 2002 Kaiser Foundation Health Plan of Washington. All rights reserved. 1 Gestational Diabetes Screening and Treatment Guideline Major Changes as of April 2018 2 Screening Recommendations and Tests 2 Diagnosis 3 Treatment Goals 3 Lifestyle modifications/non-pharmacologic options 3 Pharmacologic options 4 Additional Testing/Monitoring Antenatal monitoring 7 Follow-up after delivery 7 Referral 7 Evidence Summary 8 References 11 Guideline Development Process and Team 12 Last

2018 Kaiser Permanente Clinical Guidelines

7. Flowchart: Intrapartum management for gestational diabetes mellitus requiring Insulin and/or Metformin

Flowchart: Intrapartum management for gestational diabetes mellitus requiring Insulin and/or Metformin Document Number: F15.33--2-V1-R20 Department of Health Queensland Clinical Guidelines State of Queensland (Queensland Health) 2015 http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Queensland Clinical Guidelines, Guidelines@health.qld.gov.au Intrapartum management for GDM requiring Insulin and/or Metformin Metformin • Cease when labour established Insulin • Cease when labour

2015 Queensland Health

8. Current guidelines on the management of gestational diabetes mellitus: a content analysis and appraisal. Full Text available with Trip Pro

Current guidelines on the management of gestational diabetes mellitus: a content analysis and appraisal. Despite many guidelines for the management of gestational diabetes available internationally, little work has been done to summarize and assess the content of existing guidelines. A paucity of analysis guidelines within in a unified system may be one explanatory factor. So this study aims to analyze and evaluate the contents of all available guidelines for the management of gestational (...) of evidence, between selected evidence and interpretation, and between interpretation and resulting recommendations were analyzed.Fourteen documents were analyzed, and a total of 361 original recommendations for gestational diabetes mellitus (GDM) management were assessed. In all guidelines included, the recommendations were developed in five domains, namely, diagnosis of GDM, prenatal care, intrapartum care, neonatal care and postpartum care. Different guidelines appeared to have significant discrepancy

2019 BMC Pregnancy and Childbirth

9. Intrapartum Glucose Management in Women With Gestational Diabetes Mellitus: A Randomized Controlled Trial. (Abstract)

Intrapartum Glucose Management in Women With Gestational Diabetes Mellitus: A Randomized Controlled Trial. To assess the effect of tight compared with liberalized intrapartum maternal glucose management on neonatal hypoglycemia risk in pregnancies complicated by gestational diabetes mellitus (GDM).This was a randomized controlled trial of women with singleton gestations and GDM attempting vaginal delivery. After written informed consent, women were randomly allocated to one of two intrapartum (...) maternal glucose management protocols: tight control (glucose measurements hourly and treatment for maternal glucose levels lower than 60 mg/dL or greater than 100 mg/dL) or liberalized control (glucose measurements every 4 hours and treatment for maternal glucose levels lower than 60 mg/dL or greater than 120 mg/dL). The primary outcome was the first neonatal blood glucose level; a total sample size of 74 was necessary to have 80% power to detect a mean difference of 10 mg/dL between groups. Secondary

2019 Obstetrics and Gynecology Controlled trial quality: predicted high

10. Assessment of the methodological quality of local clinical practice guidelines on the identification and management of gestational diabetes. Full Text available with Trip Pro

Assessment of the methodological quality of local clinical practice guidelines on the identification and management of gestational diabetes. Gestational diabetes is the most common metabolic disorder of pregnancy, and it is important that well-written clinical practice guidelines (CPGs) are used to optimise healthcare delivery and improve patient outcomes. The aim of the study was to assess the methodological quality of hospital-based CPGs on the identification and management of gestational (...) diabetes.We conducted an assessment of local clinical guidelines in English for gestational diabetes using the Appraisal of Guidelines for Research and Evaluation (AGREE II) to assess and validate methodological quality.We sought a representative selection of local CPGs accessible by the internet. Criteria for inclusion were (1) identified as a guideline, (2) written in English, (3) produced by or for the hospital in a Western country, (4) included diagnostic criteria and recommendations concerning

2019 BMJ open

11. Self-management Intervention Program Based on the Health Belief Model (HBM) among Women with Gestational Diabetes Mellitus: A Quazi-Experimental Study. (Abstract)

Self-management Intervention Program Based on the Health Belief Model (HBM) among Women with Gestational Diabetes Mellitus: A Quazi-Experimental Study. The Health Belief Model (HBM) as a conceptual framework in health behavior research was applied to improve self-management. This study aimed to determine the effect of theory-based intervention program among women with gestational diabetes mellitus (GDM).This quazi-experimental study was conducted on 110 women 17-41 years old which were divided (...) randomly into intervention (n = 55) and control (n = 55) groups. The intervention group received a self-management education for four sessions lasting 35-40 minutes accompanied with a phone call as a booster. Both intervention and control groups attended a routine GDM education program at outpatient health centers. A multi-section instrument included demographics, 28 items in HBM (CVI and CVR were 0.83, 0.87, respectively) and self-management sections. All participants were invited to complete

2019 Archives of Iranian medicine Controlled trial quality: uncertain

12. Management of postprandial hyperglycaemia and weight gain in women with gestational diabetes mellitus using a novel telemonitoring system. Full Text available with Trip Pro

Management of postprandial hyperglycaemia and weight gain in women with gestational diabetes mellitus using a novel telemonitoring system. The purpose of this study was to investigate the effect of remotely delivered telemedicine dietary advice on monitoring of blood glucose levels and weight gain of women with gestational diabetes mellitus (GDM).Women with GDM were recruited and randomly allocated into two groups: a Tele-GDM group that received a telemonitoring device, and a control group

2019 The Journal of international medical research

13. Can Nurse-Based Management Screening Ensure Adequate Outcomes in Patients With Gestational Diabetes? A Comparison of 2 Organizational Models. (Abstract)

Can Nurse-Based Management Screening Ensure Adequate Outcomes in Patients With Gestational Diabetes? A Comparison of 2 Organizational Models. Gestational diabetes mellitus (GDM) is an impaired glucose tolerance with onset or first recognition during pregnancy. The purpose of this study is to evaluate the clinical outcomes of a blood glucose monitoring protocol implemented by nurses and dietitians in a diabetes team to the previously established protocol of direct monitoring of GDM patients (...) therapy (OR: 0.066 vs 0.34). In group P1 and group P2, a correlation was observed between insulin therapy and a family history of diabetes (OR: 2.20 vs 2.27), and a body mass index of greater than 30 kg/m in group P2 (OR: 3.0 vs 1.47).The data we collected show that creating a structured protocol for GDM management reduces the number of medical visits required by patients without increasing the risk of hypoglycemia, macrosomia, or hyperweight gain during pregnancy.

2019 Quality Management in Health Care

14. Management of Neonates Born at ?34 6/7 Weeks’ Gestation With Suspected or Proven Early-Onset Bacterial Sepsis

Management of Neonates Born at ?34 6/7 Weeks’ Gestation With Suspected or Proven Early-Onset Bacterial Sepsis Management of Neonates Born at ≤34 6/7 Weeks’ Gestation With Suspected or Proven Early-Onset Bacterial Sepsis | From the American Academy of Pediatrics | Pediatrics '); document.write(''); } function OAS_AD(pos) { if (OAS_version >= 11 && typeof(OAS_RICH)!='undefined') { OAS_RICH(pos); } else { OAS_NORMAL(pos); } } //--> Search for this keyword Source User menu Sections Sign up (...) for highlighting editor-chosen studies with the greatest impact on clinical care. Management of Neonates Born at ≤34 6/7 Weeks’ Gestation With Suspected or Proven Early-Onset Bacterial Sepsis Karen M. Puopolo , William E. Benitz , Theoklis E. Zaoutis , COMMITTEE ON FETUS AND NEWBORN , COMMITTEE ON INFECTIOUS DISEASES Abstract Early-onset sepsis (EOS) remains a serious and often fatal illness among infants born preterm, particularly among newborn infants of the lowest gestational age. Currently, most preterm

2018 American Academy of Pediatrics

15. SMFM Statement Pharmacological treatment of gestational diabetes Full Text available with Trip Pro

. and others x 4 Nankervis, A. and Conn, J. Gestational diabetes mellitus: negotiating the confusion. Aust Fam Physician . 2013 ; 42 : 528–531 | , x 5 Hod, M., Kapur, A., Sacks, D.A. et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet . 2015 ; 131 : S173–S211 | | support the use of oral hypoglycemic agents as first-line therapy. Despite U.S. providers’ decades (...) ., and Crowther, C.A. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev . 2017 ; 11 : CD012037 | The purpose of this Society for Maternal-Fetal Medicine (SMFM) Publications Committee statement is to review the available scientific literature regarding pharmacological treatment of GDM and to provide additional guidance to obstetric care providers regarding treatment of these women. Although this statement differs in some respects from the the American College

2018 Society for Maternal-Fetal Medicine

16. Effects of a Web-Based Self-Management Program on the Behavior and Blood Glucose Levels of Women with Gestational Diabetes Mellitus. (Abstract)

Effects of a Web-Based Self-Management Program on the Behavior and Blood Glucose Levels of Women with Gestational Diabetes Mellitus. Women diagnosed with gestational diabetes mellitus suffer from anxiety and depression, which make controlling blood glucose levels difficult.This quasi-experimental study uses a nonequivalent control group pretest-posttest design to investigate the effects of a web-based self-care program on self-care behaviors, anxiety, depression, and blood glucose in patients (...) with gestational diabetes mellitus.The subjects of the study were outpatients being treated in the Department of Endocrinology at Hospital G, located in Seoul near University C, from July 15, 2015, to December 31, 2016. The experimental and control groups contained 22 participants each. The experimental group received a 12-week web-based program and one session of nutrition education; the control group received nutrition education. Using the SPSS program, pre-post changes in blood glucose, anxiety, depression

2018 Telemedicine journal and e-health : the official journal of the American Telemedicine Association Controlled trial quality: uncertain

17. Evaluating the effects of mobile health intervention on weight management, glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus. (Abstract)

Evaluating the effects of mobile health intervention on weight management, glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus. To explore the effects of mobile health (mHealth) intervention on pregnancy weight management, blood glucose control and pregnancy outcomes.A total of 124 patients with gestational diabetes mellitus (GDM) were selected. Patients were randomly divided into two groups. The 60 patients in the control group received standard outpatient (...) group (3.2 ± 0.8 vs. 4.8 ± 0.7, t = 11.851, df = 122 p < 0.001).Mobile health intervention management of gestational diabetes mellitus improves patients' compliance and blood glucose control, and reduces weight gain, thereby reducing the rates of complications in both pregnant women and fetuses during delivery during pregnancy.

2018 Journal of endocrinological investigation Controlled trial quality: uncertain

18. Dietary Management of Gestational Diabetes in Obese Pregnant Women

Dietary Management of Gestational Diabetes in Obese Pregnant Women Dietary Management of Gestational Diabetes in Obese Pregnant Women - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Dietary Management (...) of Gestational Diabetes in Obese Pregnant Women (eMOM) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03542071 Recruitment Status : Suspended (The study protocol was changed because of too few eligible participants. A registration with revised protocol can be found by ClinicalTrials.gov ID NCT03681054

2018 Clinical Trials

19. Dietary Management of Gestational Diabetes

Dietary Management of Gestational Diabetes Dietary Management of Gestational Diabetes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Dietary Management of Gestational Diabetes (eMOM) The safety (...) body composition. The recruited women (n=60) have been diagnosed with gestational diabetes mellitus, are overweight (BMI≥25 kg/m2) and of Caucasian origin. Of the study diets, one is moderately carbohydrate restricted and the other one is high on plant-based protein with an emphasis on healthy Nordic foods. The study has two two-week study periods that are carried out on approximately gestational weeks 24-28 (period I) and 34-36 (period II). Continuous glucose monitoring and other measurements

2018 Clinical Trials

20. The Effect of E-Health Management on Gestational Diabetes Control

The Effect of E-Health Management on Gestational Diabetes Control The Effect of E-Health Management on Gestational Diabetes Control - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. The Effect of E-Health (...) Management on Gestational Diabetes Control The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03726983 Recruitment Status : Completed First Posted : November 1, 2018 Last Update Posted : November 1, 2018 Sponsor: Chang Gung Memorial Hospital Information provided by (Responsible Party): Mei-Chen Su, Chang

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>